metastatic/advanced - colorectal cancer (mCRC) | |
endometrial cancer | |
immune chekpoint inhibitors | |
anti-PD-(L)1 | |
pembrolizumab based treatment | |
pembrolizumab plus lenvatinib | KEYNOTE-775 KEYNOTE-775 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -